Literature DB >> 33063222

Evaluation of cerebral arteriovenous shunts: a comparison of parallel imaging time-of-flight magnetic resonance angiography (TOF-MRA) and compressed sensing TOF-MRA to digital subtraction angiography.

Akihiko Sakata1, Yasutaka Fushimi2, Tomohisa Okada3, Satoshi Nakajima1, Takuya Hinoda1, Peter Speier4, Michaela Schmidt4, Christoph Forman4, Kazumichi Yoshida5, Hiroharu Kataoka5, Susumu Miyamoto5, Yuji Nakamoto1.   

Abstract

PURPOSE: Time-of-flight (TOF)-MR angiography (MRA) is an important imaging sequence for the surveillance and analysis of cerebral arteriovenous shunt (AVS), including arteriovenous malformation (AVM) and arteriovenous fistula (AVF). However, this technique has the disadvantage of a relatively long scan time. The aim of this study was to compare diagnostic accuracy between compressed sensing (CS)-TOF and conventional parallel imaging (PI)-TOF-MRA for detecting and characterizing AVS.
METHODS: This study was approved by the institutional review board for human studies. Participants comprised 56 patients who underwent both CS-TOF-MRA and PI-TOF-MRA on a 3-T MR unit with or without cerebral AVS between June 2016 and September 2018. Imaging parameters for both sequences were almost identical, except the acceleration factor of 3× for PI-TOF-MRA and 6.5× for CS-TOF-MRA, and the scan time of 5 min 19 s for PI-TOF-MRA and 2 min 26 s for CS-TOF-MRA. Two neuroradiologists assessed the accuracy of AVS detection on each sequence and analyzed AVS angioarchitecture. Concordance between CS-TOF, PI-TOF, and digital subtraction angiography was calculated using unweighted and weighted kappa statistics.
RESULTS: Both CS-TOF-MRA and PI-TOF-MRA yielded excellent sensitivity and specificity for detecting intracranial AVS (reviewer 1, 97.3%, 94.7%; reviewer 2, 100%, 100%, respectively). Interrater agreement on the angioarchitectural features of intracranial AVS on CS-MRA and PI-MRA was moderate to good.
CONCLUSION: The diagnostic performance of CS-TOF-MRA is comparable to that of PI-TOF-MRA in detecting and classifying AVS with a reduced scan time under 2.5 min.

Entities:  

Keywords:  Arterial venous fistula; Arteriovenous malformation; Compressed sensing; MR angiography; Parallel imaging

Year:  2020        PMID: 33063222     DOI: 10.1007/s00234-020-02581-y

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  36 in total

1.  Contemporary Management of High-Grade Brain Arteriovenous Malformations.

Authors:  Dale Ding; Adeel Ilyas; Jason P Sheehan
Journal:  Neurosurgery       Date:  2018-09-01       Impact factor: 4.654

Review 2.  Intracranial Dural Arteriovenous Fistula as a Reversible Cause of Dementia: Case Series and Literature Review.

Authors:  Arnaldo Brito; Anderson Chun On Tsang; Christopher Hilditch; Patrick Nicholson; Timo Krings; Waleed Brinjikji
Journal:  World Neurosurg       Date:  2018-09-27       Impact factor: 2.104

3.  Risk of Brain Arteriovenous Malformation Hemorrhage Before and After Stereotactic Radiosurgery.

Authors:  Dale Ding; Ching-Jen Chen; Robert M Starke; Hideyuki Kano; John Y K Lee; David Mathieu; Caleb Feliciano; Rafael Rodriguez-Mercado; Luis Almodovar; Inga S Grills; Douglas Kondziolka; Gene H Barnett; L Dade Lunsford; Jason P Sheehan
Journal:  Stroke       Date:  2019-05-02       Impact factor: 7.914

4.  A proposed grading system for arteriovenous malformations.

Authors:  R F Spetzler; N A Martin
Journal:  J Neurosurg       Date:  1986-10       Impact factor: 5.115

Review 5.  Overview of the current concepts in the management of arteriovenous malformations of the brain.

Authors:  Aka Unnithan
Journal:  Postgrad Med J       Date:  2020-02-03       Impact factor: 2.401

6.  Treatment of dural arteriovenous fistulas.

Authors:  Vasilios Katsaridis
Journal:  Curr Treat Options Neurol       Date:  2009-01       Impact factor: 3.598

Review 7.  The Dural AV-Fistula (DAVF), the Most Frequent Acquired Vascular Malformation of the Central Nervous System (CNS).

Authors:  I Wanke; D A Rüfenacht
Journal:  Clin Neuroradiol       Date:  2015-08-26       Impact factor: 3.649

8.  A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment.

Authors:  J A Borden; J K Wu; W A Shucart
Journal:  J Neurosurg       Date:  1995-02       Impact factor: 5.115

Review 9.  Brainstem Congestion Due to Dural Arteriovenous Fistula at the Craniocervical Junction: Case Report and Review of the Literature.

Authors:  Xiao-Chun Wang; Yan-Yao Du; Yan Tan; Jiang-Bo Qin; Le Wang; Xiao-Feng Wu; Xin Liang; Lei Zhang; Li-Na Li; Xin Zhou; Dui-Ping Feng; Guo-Lin Ma; Hui Zhang
Journal:  World Neurosurg       Date:  2018-08-07       Impact factor: 2.104

Review 10.  Outcome after intracranial haemorrhage from dural arteriovenous fistulae; a systematic review and case-series.

Authors:  W M T Jolink; J M C van Dijk; C J J van Asch; G A P de Kort; A Algra; R J M Groen; G J E Rinkel; C J M Klijn
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

View more
  3 in total

1.  MRI and MR angiography evaluation of pulsatile tinnitus: A focused, physiology-based protocol.

Authors:  Daniel D Cummins; Michael T Caton; Vinil Shah; Karl Meisel; Christine Glastonbury; Matthew R Amans
Journal:  J Neuroimaging       Date:  2021-12-15       Impact factor: 2.486

2.  Follow-Up Assessment of Intracranial Aneurysms Treated with Endovascular Coiling: Comparison of Compressed Sensing and Parallel Imaging Time-of-Flight Magnetic Resonance Angiography.

Authors:  Gianfranco Vornetti; Fiorina Bartiromo; Francesco Toni; Massimo Dall'Olio; Mario Cirillo; Peter Speier; Ciro Princiotta; Michaela Schmidt; Caterina Tonon; Domenico Zacà; Raffaele Lodi; Luigi Cirillo
Journal:  Tomography       Date:  2022-06-18

Review 3.  Vessel wall MR imaging in neuroradiology.

Authors:  Yasutaka Fushimi; Kazumichi Yoshida; Masakazu Okawa; Takakuni Maki; Satoshi Nakajima; Akihiko Sakata; Sachi Okuchi; Takuya Hinoda; Mitsunori Kanagaki; Yuji Nakamoto
Journal:  Radiol Med       Date:  2022-07-30       Impact factor: 6.313

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.